Loading... (0%)

Blockbuster Hepatitis-C Drug Sovaldi pushes Gilead’s (GILD) Up In the Race

Hepatitis C super drug Sovaldi, raised the shares of its company, Gilead ($GILD), to soar a five-year-high of $84.88 per share,…

NEWSLETTER SIGNUP 

Now
17 °
Tokyo, Japan